China Universal Asset Management Co., Ltd. Amicus Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 56,751 shares of FOLD stock, worth $556,727. This represents 0.09% of its overall portfolio holdings.
Number of Shares
56,751
Previous 56,751
-0.0%
Holding current value
$556,727
Previous $669,000
0.15%
% of portfolio
0.09%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$277 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$275 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$269 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$224 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$184 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.75B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...